Skip to main content
SeouLinBioscienceCO.,LTD. logo

SeouLinBioscienceCO.,LTD. — Investor Relations & Filings

Ticker · 038070 ISIN · KR7038070009 KO Professional, scientific and technical activities
Filings indexed 209 across all filing types
Latest filing 2020-03-30 Annual Report
Country KR South Korea
Listing KO 038070

About SeouLinBioscienceCO.,LTD.

SeouLin Bioscience is a total solutions provider for the life sciences and healthcare sectors, specializing in bio-research and production. Established in 1984, the company supplies a comprehensive range of research reagents, laboratory equipment, and materials. It also develops and manufactures specialized products, including Hypochlorous Acid (HOCl) sterilization water generators, DNA chip scanners, and diagnostic DNA kits. The company's research and development activities focus on creating novel diagnostic solutions, such as field kits for detecting marine viruses and pathogens related to food safety. SeouLin Bioscience aims to deliver integrated solutions that support scientific discovery and bioproduction processes.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Annual Report Classification · 1% confidence The document is a 'Connected Audit Report' (연결감사보고서) for Seorin Bioscience for the fiscal year ending December 31, 2019. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. As it contains full audited financial statements for a specific fiscal period, it is classified as an Annual Report (10-K). FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and director appointments. This is a formal record of the voting outcomes from a general meeting, which fits the definition of a Declaration of Voting Results.
2020-03-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (market purchase/sale), and changes in collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-03-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). It details the specific share transactions (purchases) made by an executive (Kang Mi-ok) of Seoulin Bioscience. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which falls under the 'Director's Dealing' category.
2020-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Seoulin Bioscience. It contains the meeting agenda, details on voting, director/auditor nominations, and financial statements (balance sheets). This type of document is distributed to shareholders to provide information and request votes for the upcoming AGM, which fits the definition of a Proxy Solicitation & Information Statement.
2020-03-04 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Seorin Bio. It provides a summary of the audit opinion (which is '적정' or 'unqualified') and key financial data (assets, liabilities, revenue, net income) for both consolidated and separate financial statements. While it contains financial data, it is a standard regulatory announcement notifying the market that the audit report has been submitted, rather than the full annual report (10-K) itself. According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2019
2020-03-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.